BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies. [electronic resource]
Producer: 20141007Description: 1657-65 p. digitalISSN:- 1476-5551
- Antimetabolites, Antineoplastic -- pharmacology
- Azacitidine -- pharmacology
- Biphenyl Compounds -- pharmacology
- Bridged Bicyclo Compounds, Heterocyclic -- pharmacology
- Cell Line, Tumor
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Myelodysplastic Syndromes -- drug therapy
- Myeloid Cell Leukemia Sequence 1 Protein -- antagonists & inhibitors
- Myeloproliferative Disorders -- drug therapy
- Nitrophenols -- pharmacology
- Piperazines -- pharmacology
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- RNA Interference
- Sulfonamides -- pharmacology
- bcl-X Protein -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.